表紙
市場調查報告書
商品編碼
939528

血管閉塞設備市場

Vascular Closure Devices

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 477 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球血管閉塞設備市場在預測期間內預計將以5.8%的年複合成長率推移,並成長到3億7,460萬美元。

本報告提供全球血管閉塞設備市場的相關調查,市場佔有率,提供著趨勢和成長要素,新型冠狀病毒感染疾病的影響,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

本報告刊載的企業資料:Abbott Laboratories, Inc.·Cardinal Health, Inc.·Cardiva Medical, Inc.·Essential Medical, Inc.·Inseal Medical Ltd.·Medtronic PLC·Merit Medical Systems, Inc.·Terumo Corporation·Tricol Biomedical, Inc.·Tz Medical, Inc.·Vasorum Ltd.·Vivasure Medical Ltd.

目錄

簡介,調查手法,調查範圍

摘要整理

第1章 市場概要

  • 全球競爭市場佔有率
  • 全球競爭市場佔有率方案
  • 新型冠狀病毒感染疾病的影響,全球景氣衰退

第2章 關注的企業

第3章 市場趨勢及成長要素

第4章 全球市場預測

市場分析

  • 各地區市場分析
  • 美國
    • 市場現狀·要點
    • 市場佔有率:各企業
    • 市場分析
  • 加拿大
  • 日本
  • 中國
  • 歐洲
    • 市場現狀·要點
    • 競爭的市場佔有率方案
    • 市場分析
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

競爭

  • 企業簡介
目錄
Product Code: MCP15452

Abstract:

Global Vascular Closure Devices Market to Reach $1.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Vascular Closure Devices estimated at US$731.5 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027. Passive Approximators, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$783.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Active Approximators segment is readjusted to a revised 6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $302.2 Million, While China is Forecast to Grow at 8.2% CAGR

The Vascular Closure Devices market in the U.S. is estimated at US$302.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$119.6 Million by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

External Hemostatic Devices Segment to Record 4.6% CAGR

In the global External Hemostatic Devices segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$91.9 Million in the year 2020 will reach a projected size of US$125.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$87.6 Million by the year 2027, while Latin America will expand at a 4.9% CAGR through the analysis period.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Advanced Vascular Dynamics
  • Cardinal Health, Inc.
  • Cardival Medical, Inc.
  • Endocor GmbH
  • Medtronic PLC
  • Merit Medical Systems Inc.
  • Morris Innovative Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Transluminal Technologies LLC
  • Tricol Medical Inc.
  • Vivasure Medical Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Vascular Closure Devices - A Prelude
    • Benefits
    • Active Approximators
    • Passive Approximators
    • External Hemostatic Devices
    • Vascular Closure Devices to Witness Steady Growth Post COVID-19
    • Interventional Cardiology to Dominate the Market
    • Passive Approximators Lead the Market
    • Femoral Access Type Leads the Market
    • United States Holds a Dominant Share, Asia-Pacific to Witness Rapid Growth
    • Competition
    • Growth Restraints
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Medical Device Companies Focus on Developing Advanced Biomechanical VCDs
    • Increasing Demand for Large-bore Vascular Closure Devices
    • Select Large Bore Closure Devices
    • Cardiovascular Diseases: A Significant Contributor to Market Growth
    • EXHIBIT 1: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • EXHIBIT 2: Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
    • Rising Preference for Minimally Invasive Procedures Boosts Market Prospects
    • Aging Population Drives Demand for Vascular Closure Devices
    • EXHIBIT 3: Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
    • Life Expectancy for Select Countries in Number of Years: 2019
    • Increasing Healthcare Expenditure to Foster Growth
    • World Healthcare Expenditure (In US$ Trillion) for the Years 2016 & 2018
    • Recent Approvals and Launches
    • Essential Medical Inc Receives FDA Clearance for its Large-Bore Vascular Closure Device
    • Vascade MVP Vascular Closure System Obtains Approval from FDA
    • Large Bore PerQseal Closure Device Introduced in Europe
    • Cordis Introduces Mynx Control Vascular Closure Device
    • FDA Approves Teleflex's Vascular Closure Device
    • Vasorum Set to Commercialize a New Vascular Closure Device across the US
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Vascular Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Vascular Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Passive Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Passive Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Passive Approximators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Active Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Active Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Active Approximators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for External Hemostatic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for External Hemostatic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for External Hemostatic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Interventional Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Interventional Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Interventional Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Interventional Radiology/Vascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Interventional Radiology/Vascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Interventional Radiology/Vascular Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Femoral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Femoral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Femoral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Radial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Radial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Radial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 25: USA Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 28: USA Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 34: Canada Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 37: Canada Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Canada 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 40: Canada Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Canada Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Canada 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • JAPAN
    • Graying Population Spurs Growth of Vascular Closure Devices
    • TABLE 24: Japanese Population by Age Group (2015 & 2040): Percentage Share Breakdown of Population for 0-14, 15-64 and 65 & Above Age Groups
    • TABLE 43: Japan Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Japan Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Japan 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 46: Japan Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Japan Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Japan 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 49: Japan Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Japan Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Japan 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 52: China Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: China Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: China 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 55: China Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: China Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: China 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 58: China Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: China Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: China 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • EUROPE
    • Ageing Demography - An Opportunity Indicator
    • EXHIBIT 4: European Population by Age Group (2016, 2030 & 2050): Percentage Share Breakdown by Age Group for 0-14, 15-64, and 65 & Above
    • TABLE 61: Europe Current & Future Analysis for Vascular Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 62: Europe Historic Review for Vascular Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: Europe 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 64: Europe Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Europe Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Europe 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 67: Europe Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Europe Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Europe 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 70: Europe Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Europe 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 73: France Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: France Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: France 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 76: France Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: France Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: France 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 79: France Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: France Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: France 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 82: Germany Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Germany Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: Germany 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 85: Germany Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Germany Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Germany 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 88: Germany Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Germany Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Germany 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 91: Italy Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Italy Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Italy 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 94: Italy Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Italy Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Italy 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 97: Italy Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Italy Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Italy 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 100: UK Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: UK Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: UK 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 103: UK Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: UK Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: UK 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 106: UK Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: UK Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: UK 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 109: Spain Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Spain Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: Spain 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 112: Spain Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Spain Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: Spain 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 115: Spain Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Spain Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Spain 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 118: Russia Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Russia Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Russia 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 121: Russia Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Russia Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Russia 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 124: Russia Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Russia Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Russia 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 127: Rest of Europe Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Rest of Europe Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Rest of Europe 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 130: Rest of Europe Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Europe Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Rest of Europe 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 133: Rest of Europe Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Europe Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Europe 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • Aging Populace - Potential Opportunities
    • EXHIBIT 5: Over 65 Years Individuals as % of the Total Population in Select Asian Countries
    • Healthcare Spending on the Rise
    • TABLE 136: Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 137: Asia-Pacific Historic Review for Vascular Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 139: Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Asia-Pacific Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 142: Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Asia-Pacific Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Asia-Pacific Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 148: Australia Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Australia Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Australia 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 151: Australia Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Australia Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Australia 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 154: Australia Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Australia Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Australia 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 157: India Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: India Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: India 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 160: India Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: India Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: India 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 163: India Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: India Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: India 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 166: South Korea Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: South Korea Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: South Korea 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 169: South Korea Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: South Korea Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: South Korea 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 172: South Korea Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: South Korea Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: South Korea 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 175: Rest of Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Rest of Asia-Pacific Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: Rest of Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 178: Rest of Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Rest of Asia-Pacific Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: Rest of Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 181: Rest of Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Rest of Asia-Pacific Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Rest of Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 184: Latin America Current & Future Analysis for Vascular Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 185: Latin America Historic Review for Vascular Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Latin America 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 187: Latin America Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Latin America Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Latin America 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 190: Latin America Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Latin America Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Latin America 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 193: Latin America Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Latin America Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Latin America 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 196: Argentina Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Argentina Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: Argentina 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 199: Argentina Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Argentina Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Argentina 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 202: Argentina Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Argentina Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Argentina 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 205: Brazil Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Brazil Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Brazil 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 208: Brazil Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Brazil Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Brazil 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 211: Brazil Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Brazil Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Brazil 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 214: Mexico Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Mexico Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 216: Mexico 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 217: Mexico Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 218: Mexico Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 219: Mexico 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 220: Mexico Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 221: Mexico Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 222: Mexico 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 223: Rest of Latin America Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 224: Rest of Latin America Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 225: Rest of Latin America 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 226: Rest of Latin America Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 227: Rest of Latin America Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 228: Rest of Latin America 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 229: Rest of Latin America Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 230: Rest of Latin America Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 231: Rest of Latin America 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 232: Middle East Current & Future Analysis for Vascular Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 233: Middle East Historic Review for Vascular Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 234: Middle East 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 235: Middle East Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 236: Middle East Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 237: Middle East 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 238: Middle East Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 239: Middle East Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 240: Middle East 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 241: Middle East Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 242: Middle East Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 243: Middle East 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 244: Iran Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 245: Iran Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 246: Iran 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 247: Iran Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 248: Iran Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 249: Iran 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 250: Iran Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 251: Iran Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 252: Iran 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 253: Israel Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 254: Israel Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 255: Israel 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 256: Israel Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 257: Israel Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 258: Israel 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 259: Israel Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 260: Israel Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 261: Israel 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 262: Saudi Arabia Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 263: Saudi Arabia Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 264: Saudi Arabia 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 265: Saudi Arabia Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 266: Saudi Arabia Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 267: Saudi Arabia 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 268: Saudi Arabia Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 269: Saudi Arabia Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 270: Saudi Arabia 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 271: UAE Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 272: UAE Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 273: UAE 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 274: UAE Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 275: UAE Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 276: UAE 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 277: UAE Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 278: UAE Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 279: UAE 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 280: Rest of Middle East Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 281: Rest of Middle East Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 282: Rest of Middle East 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 283: Rest of Middle East Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 284: Rest of Middle East Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 285: Rest of Middle East 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 286: Rest of Middle East Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 287: Rest of Middle East Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 288: Rest of Middle East 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 289: Africa Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 290: Africa Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 291: Africa 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 292: Africa Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 293: Africa Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 294: Africa 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 295: Africa Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 296: Africa Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 297: Africa 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 36